Dietary oleic and palmitic acids modulate the ratio of triacylglycerols to cholesterol in postprandial triacylglycerol-rich lipoproteins in men and cell viability and cycling in human monocytes

Journal of Nutrition

Volumn 137, Issue 9, 2007, Pages 1999-2005

  López, Sergio ^a   Bermúdez, Beatriz ^a   Pacheco, Yolanda M ^a   López Lluch, Guillermo ^b   Moreda, Wenceslao ^a   Villar, José ^c   Abia, Rocío ^a   Muriana, Francisco J G ^a  

^a INSTITUTO DE LA GRASA   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITIC ACID; TRIACYLGLYCEROL;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; BODY SURFACE; BUTTER; CELL CYCLE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; DIETARY INTAKE; FAT INTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID METABOLISM; MALE; MEN'S HEALTH; MONOCYTE; NORMAL HUMAN; POSTPRANDIAL STATE; SUNFLOWER;

HELIANTHUS;

EID: 34548411459     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.9.1999     Document Type: Article

References (49)

1. Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep. 2003;5:437-44.
2. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb. 2004;11:322-9.
3. Williams CM. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis. 1998;141 Suppl 1:S87-92.
4. Chung BH, Cho BHS, Liang P, Doran S, Osterlund L, Oster RA, Darnell B, Franklin F. Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr. 2004;80:1145-58.
5. Tholstrup T, Sandström B, Bysted A, Holmer G. Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipase, and cholesterol ester transfer activities in healthy young men. Am J Clin Nutr. 2001;73:198-208.
6. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol. 2006;98 Suppl 1:27-33.
7. Jackson KG, Wolstencroft EJ, Bateman PA, Yaqoob P, Williams CM. Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C-III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids. Am J Clin Nutr. 2005;81:25-34.
8. Thomsen C, Rasmusen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr. 1999;69:1135-43.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
10. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington: National Academies Press; 2002.
11. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem. 2005;12:1931-45.
12. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779-84.
13. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503-16.
14. Yu KCW, Mamo JCL. Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin Sci. 2000;98:183-92.
15. Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 2006;37:208-22.
16. Choudhury RP, Lee JM, Greaves DR. Mechanisms of disease: macrophagederived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med. 2005;2:309-15.
17. Brinton EA, Nanjee MN, Hopkins PN. Triglyceride-rich lipoprotein remnant levels and metabolism. J Am Coll Cardiol. 2004;43:2233-5.
18. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles. Disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006;26:2594-604.
19. Liu ML, Reilly MP, Casasanto P, McKenzie SE, Williams KJ. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol. 2007;27:430-5.
20. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005;25:2255-64.
21. Ludewig B, Laman JD. The in and out of monocytes in atherosclerotic plaques: balancing inflammation through migration. Proc Natl Acad Sci USA. 2004;101:11529-30.
22. Pacheco YM, Bermudez B, Lopez S, Abia R, Villar J, Muriana FJG. Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men. Am J Clin Nutr. 2006;84:342-9.
23. EEC. Commission regulation (EEC) no 796/02 of 6 May 2002 amending regulation EEC2568/91 on the characteristics of olive oil and olive residue oil and on the relevant methodology analysis. Off J Eur Commun. 2002;L128:8-28.
24. Abia R, Pacheco YM, Perona JS, Montero E, Muriana FJG, Ruiz-Gutierrez V. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J Nutr. 2001;131:59-65.
25. Garces R, Mancha M. One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal Biochem. 1993;211:139-43.
26. Bello RI, Gomez-Diaz C, Lopez-Lluch G, Forthoffer N, Cordoba-Pedregosa MC, Navas P, Villalba JM. Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism. Biochem Pharmacol. 2005;69:1613-25.
27. Edwards K, Chan RY, Sawyer WH. Interactions between fatty acids and lipoprotein lipase: specific binding and complex formation. Biochemistry. 1994;33:13304-11.
28. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res. 2003;44:455-63.
29. Park Y, Jones PG, Harris WS. Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr. 2004;80:45-50.
30. Blackburn P, Cote M, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Despres JP. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism. 2003;52:1379-86.
31. Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EHM, Desrumaux C, Athias A, Hornstra G, Gambert P. Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis. 1999;142:395-402.
32. Callow J, Summers LKM, Bradshaw H, Frayn KN. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fats. Am J Clin Nutr. 2002;76:345-50.
33. Perez-Mendez O, Alvarez-Salcedo P, Carreon E, Luc G, Arce M, De la Peña A, Cruz D, Garcia JJ, Vargas-Alarcon G. Palmitic acid in HDL is associated to low apo A-I fractional catabolic rates in vivo. Clin Chim Acta. 2007;378:53-8.
34. Bagdade JD, Ritter M, Subbaiah PV. Marine lipids normalize cholesteryl ester transfer in IDDM. Diabetologia. 1996;39:487-91.
35. Chung BH, Segrest JP, Smith K, Griffin FM, Brouillette CG. Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis? J Clin Invest. 1989;83:1363-74.
36. Iturralde M, Gamen S, Pardo J, Bosque A, Pineiro A, Alava MA, Naval J, Anel A. Saturated free fatty acid release and intracellular ceramide generation during apoptosis induction are closely related processes. Biochim Biophys Acta. 2003;1634:40-51.
37. Lupi R, Del Guerra S, Fierabracci V, Marselli L, Novelli M, Patane G, Boggi U, Mosca F, Piro S, et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes. 2002;51 Suppl 1:S134-7.
38. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 2003;100:3077-82.
39. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935-45.
40. Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA, Passerini AG, Simon SI. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res. 2007;100:381-90.
41. Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bessede G, Pais de Barros JP, Laubriet A, Gambert P, et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 2004;11:897-905.
42. Seo T, Qi K, Chang C, Liu Y, Worgall TS, Ramakrishnan R, Deckelbaum RJ. Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. J Clin Invest. 2005;115:2214-22.
43. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ. 2004;11:S12-6.
44. Qiu G, Ho AC, Yu W, Hill JS. Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion. J Lipid Res. 2007;48:385-94.
45. Albi E, Viola Magni MO. The role of intranuclear lipids. Biol Cell. 2004;96:657-67.
46. Morgan DO. Principles of CDK regulation. Nature. 1995;374:131-4.
47. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP. Cell-cycle in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J. 2003;371:621-9.
48. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erb B-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005;16:359-71.
49. Khan NA, Nishimura K, Aires V, Yamashita T, Oaxaca-Castillo D, Kashiwagi K, Igarashi K. Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation. J Lipid Res. 2006;47:2306-13.